Advertisement

Structure-Activity Relationships of MDMA and Related Compounds: A New Class of Psychoactive Agents?

  • David F. Nichols
  • Robert Oberlender
Part of the Topics in the Neurosciences book series (TNSC, volume 9)

Abstract

It has been hypothesized that MDMA and substances that possess a psychopharmacological effect similar to MDMA are members of a novel pharmacological class named entactogens [1–3]. In this chapter evidence will be presented to support this, through a discussion of the data acquired in efforts directed toward testing this hypothesis. Although these studies are far from complete, the results gathered thus far, together with those from other laboratories, support the view that the pharmacology of entactogens is clearly different from other known classes of compounds.

Keywords

Discriminative Stimulus Drug Discrimination Training Dose Complete Substitution Discriminative Stimulus Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nichob. D.E., Hoffman. A.J. Obetlender. R.A., Jacob III. P., and Shulgin. A T., 1986 Derivatives of Hl.3-bemodioxol-5-yl)-2-butaiiainMe: Representatives of a rove! therapeutic class. J. Med. Chein. 29: 2009–2015.CrossRefGoogle Scholar
  2. 2.
    Nichols. D.E. 1986 Differences between the mechanisms of action of MDV.A. MBDB. and the classical hallucinogens. Identification of a new therapeutic class: Entactogens. J. Psychoactive Drugs 18: 305–313.PubMedGoogle Scholar
  3. 3.
    Oberlender. R and Nichob. D.E., 1988 Drug discrimination studies with MDMA and amphetamine. Psychophatmacology 95: 71–76.Google Scholar
  4. 4.
    Jaffe. J.H., 1985. Drug addiction and drug abuse. In The Pharmacological Basis of Therapeutics, Seventh Edition. (Gilnun. A G., Goodman. L.S., Rail. T.W. Murad. F. cds). New York. MacmilLan Publishing Company, pp. 523–581Google Scholar
  5. 5.
    Werner. N., 1980. Norepinephrine, epinephrine, and the sypalhominietic amines. In The Pharmacological Basis of Therapeutics, Sixth Edition, ( Gilrnan, A.G., Gooiman. L.S. and Gilman. A., cds.) New York: Macmillan. pp 138–175Google Scholar
  6. 6.
    Greer. G. and Tolbcrt. R., 1986 Subjective reports of the effects of MDMA in a clinical setting. J. Psychoactive Drugs 18: 319–327.Google Scholar
  7. 7.
    Stolerman. I P. and D’Mello G.D. 1981 Role of training conditions in dsenmination of central nervous system stimulants by rats. Psychopharnuoology 73: 295–303.CrossRefGoogle Scholar
  8. 8.
    Barry. H., 1974 Classification of drugs according to their discriminate effects in rats. Fed. Proc. 33: 1814–1824.PubMedGoogle Scholar
  9. 9.
    Overton. D.A., (1984). State dependent learning and drug discrimuiatioits In HanJkodt of PyHhopharmHelegy. Vol. 18 (lvcrsen. L.L., Ivcrscn. S.D and Snyder. S.H.cds.) New York: Plenum Press, pp. 59–126Google Scholar
  10. 10.
    Weil. A., 1976 The love drug. J. Psychoactive Drugs 8: 335–337Google Scholar
  11. 11.
    Turek. I S., Soskiri. R A. and Kurland. A A., 1974 Meihyleitedioxyamphctainine (MDA) Subjective effects J Psychedelic Dnigs 6:7–14128 7. Structure-Activity Relationships of MDMA and Related CompoundsGoogle Scholar
  12. 12.
    Shannon, H.E., 1980. MDA and DOM: Substituted amphetamines that do not produce amphetamine-like discriminative stimuli in the rat. Psychopharnucology 67: 311–312.CrossRefGoogle Scholar
  13. 13.
    Glennon, R.A., Rosccrans. J A., and Young, R. 1981 Behavioral properties of psychoactive phcnylisopiopylainincs in ran Eur J Pharmacol. 76: 353–360.PubMedCrossRefGoogle Scholar
  14. 14.
    Glctinon. R.A. and Young. R., 19R4. MDA: An agent that produces stimulus effects similar to those of 3.4-DMA. LSD and cocaine. Fair. J. Pharmacol. 99: 249–250.Google Scholar
  15. 15.
    Glennon. R.A and Young. R., 1984. MDA: A psychoactive agent with dual stimulus effects. Life So. 34: 379–383Google Scholar
  16. 16.
    Shulgui. A.T., 1978. Psychotomimetic drugs Structure-activity relationships. In Handbook of Psychopharmacology. Vol 11 (lversen, L.L., lversen, S I), and Snyder. S.H., eds.). New York: Plenum, pp. 243–333.Google Scholar

Copyright information

© Kluwer Academic Publishers 1990

Authors and Affiliations

  • David F. Nichols
  • Robert Oberlender

There are no affiliations available

Personalised recommendations